The shockpulse-se™, a new lithotripsy system by olympus. Evaluation of its efficacy in comparison to the lithoclast master™ device by ems

Giusti, G.; Chiarissi, M. Lucci; Caria, N.; Vita, Giulia; Petrucci, F.; Napoli, Renata; Cristofano, Francesca Di; Angelini, L; Valerio, S.; Lisa, Antonello De

doi:10.1016/s1569-9056(19)33724-8

Cited by 3 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the Trilogy series by Nottingham et al [ 3 ], stone-free rates were lower (67%). In comparison, clinical evaluation of ShockPulse-SE has shown high stone-free rates of 78–83% [ 7 , 12 ] and are higher than those for LC Master [ 13 ]. A randomised controlled trial by York et al [ 14 ], which evaluated Cyberwand, LC Select and StoneBreaker showed stone-free rates of 56.5%, 65.2% and 51.6%, respectively.…”

Section: Discussionmentioning

confidence: 99%

Efficacy and safety of the EMS Swiss LithoClast® Trilogy for PCNL: results of the European multicentre prospective study on behalf of European Section of UroTechnology

et al. 2021

View full text Add to dashboard Cite

Purpose PCNL requires a lithotrite to efficiently break stones, and some devices include active suction to remove the fragments. We set out to determine the efficacy and safety of the Swiss LithoClast® Trilogy, in a prospective European multicentre evaluation and compared it to published stone clearance rates for Trilogy based on surface area (68.9 mm 2 /min) and using the 3D calculated stone volume (526.7 mm 3 /min). Methods Ten European centres participated in this prospective non-randomized study of Trilogy for PCNL. Objective measures of stone clearance rate, device malfunction, complications and stone-free rates were assessed. Each surgeon subjectively evaluated ergonomic and device effectiveness, on a 1-10 scale (10 = extremely ergonomic/effective) and compared to their usual lithotrite on a 1-10 scale (10 = extremely effective). Results One hundred and fifty seven PCNLs using Trilogy were included (53% male, 47% female; mean age 55 years, range 13-84 years). Mean stone clearance rate was 65.55 mm 2 /min or 945 mm 3 /min based on calculated 3D volume. Stone-free rate on fluoroscopy screening at the end of the procedure was 83%. Feedback for suction effectiveness was 9.0 with 9.1 for combination and 9.0 for overall effectiveness compared to lithotrite used previously. Ergonomic score was 8.1, the least satisfactory element. Complications included 13 (8.2%) Clavien-Dindo Grade II and 2 (1.3%) Grade III. Probe breakage was seen in 9 (5.7%), none required using a different lithotrite. Conclusions We have demonstrated that Trilogy is highly effective at stone removal. From a user perspective, the device was perceived by surgeons to be highly effective overall and compared to the most commonly used previous lithotrite, with an excellent safety profile.

show abstract

Section: Discussionmentioning

confidence: 99%

Efficacy and safety of the EMS Swiss LithoClast® Trilogy for PCNL: results of the European multicentre prospective study on behalf of European Section of UroTechnology

et al. 2021

View full text Add to dashboard Cite

show abstract

“…In a prospective randomized clinical trial evaluating the ablation rate and type of complications (Giusti et al), the ShockPulse-SE had a significant higher speed than the one of the Lithoclast Master. 19 Our final comparison was conducted in vivo, on a porcine model, between the two best devices proven in the first part of the experiment (the Lithoclast Trilogy and the ShockPulse-SE), using exclusively single-use probes with identical diameter (3.4 mm).…”

Section: Discussionmentioning

confidence: 99%

Comparative Evaluation Between One Ultrasonic and Two Single-Probe Dual-Energy Lithotripters: In Vitro and In Vivo Experiment in a Porcine Model

Lattarulo

Tsaturyan

Adamou

et al. 2021

Journal of Endourology

View full text Add to dashboard Cite

Objective: To investigate the efficiency of three advanced lithotripters during the treatment of artificial stones (hard and soft) in an experimental in vitro and in vivo setting. Materials and Methods: An experimental configuration was created to treat artificial stones, made from BegoStone Plus in a weight ratio of 15:3 or 15:6 powder to water, replicating hard and soft urinary stones, respectively. Experimental data of three lithotripters, the Lithoclast Master, the Lithoclast Trilogy, and the ShockPulse-SE, were assessed. Experiments aimed at comparing the stone clearance times (SCTs) of the devices as well as different probe diameters, probe disposability, and hardness of the stones. The in vivo experiment was performed in a porcine model after the approval from the State Services. Before in vivo lithotripsy, stones had been placed through percutaneous access established by using the Bull's eye technique. The SCT between the Lithoclast Trilogy and the ShockPulse-SE was compared. Results: All the devices were statistically more efficient in the treatment of soft stones in both in vitro ( p < 0.001) and in vivo settings ( p < 0.008). The use of larger-diameter probes resulted in shorter SCT ( p < 0.007). The disposable probes of the ShockPulse-SE showed higher performance than the multiple-use probes ( p < 0.05). In the direct comparison between the devices, the Lithoclast Trilogy was found to be the fastest during all the in vitro ( p < 0.001) and in vivo ( p < 0.008) trials. Conclusion: Modern dual-energy lithotripters proved to possess high performance in the treatment of stones. Faster SCTs were observed by using the larger-diameter and disposable probes. The Lithoclast Trilogy was superior in terms of SCT over all the experimental settings compared with other lithotripters.

show abstract

Assessment of single-probe dual-energy lithotripters in percutaneous nephrolithotomy: a systematic review and meta‐analysis of preclinical and clinical studies

et al. 2023

View full text Add to dashboard Cite

The shockpulse-se™, a new lithotripsy system by olympus. Evaluation of its efficacy in comparison to the lithoclast master™ device by ems

Cited by 3 publications

References 0 publications

Efficacy and safety of the EMS Swiss LithoClast® Trilogy for PCNL: results of the European multicentre prospective study on behalf of European Section of UroTechnology

Efficacy and safety of the EMS Swiss LithoClast® Trilogy for PCNL: results of the European multicentre prospective study on behalf of European Section of UroTechnology

Comparative Evaluation Between One Ultrasonic and Two Single-Probe Dual-Energy Lithotripters: In Vitro and In Vivo Experiment in a Porcine Model

Assessment of single-probe dual-energy lithotripters in percutaneous nephrolithotomy: a systematic review and meta‐analysis of preclinical and clinical studies

Contact Info

Product

Resources

About